Honda, M.; Kataoka, M.; Iima, M.; Ota, R.; Ohashi, A.; Kishimoto, A.O.; Miyake, K.K.; Nickel, M.D.; Yamada, Y.; Toi, M.;
et al. Correction: Honda et al. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522–1533. Tomography 2026, 12, 6.
https://doi.org/10.3390/tomography12010006
AMA Style
Honda M, Kataoka M, Iima M, Ota R, Ohashi A, Kishimoto AO, Miyake KK, Nickel MD, Yamada Y, Toi M,
et al. Correction: Honda et al. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522–1533. Tomography. 2026; 12(1):6.
https://doi.org/10.3390/tomography12010006
Chicago/Turabian Style
Honda, Maya, Masako Kataoka, Mami Iima, Rie Ota, Akane Ohashi, Ayami Ohno Kishimoto, Kanae Kawai Miyake, Marcel Dominik Nickel, Yosuke Yamada, Masakazu Toi,
and et al. 2026. "Correction: Honda et al. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522–1533" Tomography 12, no. 1: 6.
https://doi.org/10.3390/tomography12010006
APA Style
Honda, M., Kataoka, M., Iima, M., Ota, R., Ohashi, A., Kishimoto, A. O., Miyake, K. K., Nickel, M. D., Yamada, Y., Toi, M., & Nakamoto, Y.
(2026). Correction: Honda et al. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522–1533. Tomography, 12(1), 6.
https://doi.org/10.3390/tomography12010006
